develop
experiment
recombin
vesicular
stomat
viru
vsv
vector
plagu
vaccin
express
secret
form
yersinia
pesti
lcrv
protein
first
posit
vsv
genom
vector
given
intramuscularli
singl
dose
induc
highlevel
antibodi
titer
lcrv
gave
protect
pneumon
plagu
challeng
mice
singledos
protect
significantli
better
gener
vsv
express
nonsecret
lcrv
protein
increas
protect
correl
increas
antilcrv
antibodi
bia
toward
away
isotyp
also
found
deplet
cell
cell
time
challeng
result
reduc
vaccin
protect
indic
role
cellular
immun
protect
yersinia
pesti
gramneg
bacillu
primarili
caus
diseas
small
rodent
occasion
also
infect
human
via
infect
rodent
flea
bite
therebi
caus
bubon
plagu
untreat
bubon
plagu
progress
highli
contagi
pneumon
form
diseas
associ
high
mortal
human
also
contract
pneumon
plagu
inhal
aerosol
infecti
droplet
follow
direct
contact
infect
individu
thu
allow
rapid
spread
diseas
antibiot
treatment
margin
effect
rapidli
progress
oftenfat
natur
pneumon
plagu
pose
danger
public
health
worldwid
addit
possibl
intent
use
aerosol
pesti
antibioticresist
form
bioterror
agent
loom
threat
vaccin
plagu
one
approach
pursu
deal
impend
infect
howev
safe
effect
pneumon
plagu
vaccin
human
yet
avail
unit
state
current
vaccin
develop
strategi
focu
pesti
antigen
two
major
candid
outer
capsul
protein
low
calcium
respons
protein
v
lcrv
induc
good
protect
immun
respons
challeng
pathogen
vaccin
base
alon
fail
protect
virul
strain
lcrv
base
subunit
vaccin
confer
protect
pesti
strain
lcrv
kda
protein
essenti
virul
critic
product
transloc
yersinia
outer
protein
yop
eukaryot
cell
cytosol
although
mechan
protect
elicit
lcrvbase
vaccin
poorli
understood
number
studi
shown
antibodi
lcrv
gener
either
activ
passiv
immun
protect
diseas
mous
model
recent
induct
lcrvspecif
broad
tcell
immun
also
report
role
protect
remain
elucid
previous
report
develop
experiment
pneumon
plagu
vaccin
base
attenu
recombin
vesicular
stomat
viru
rvsv
vector
express
yersinia
pesti
lcrv
protein
vsv
negativestrand
rna
viru
encod
five
structur
protein
nucleocapsid
n
phosphoprotein
p
matrix
glycoprotein
g
rna
depend
rna
polymeras
l
viru
natur
pathogen
livestock
human
infect
rare
typic
asymptomat
vsv
recombin
attenu
pathogenesi
mice
compar
natur
occur
vsv
strain
gener
plasmid
dna
also
caus
diseas
symptom
nonhuman
primat
given
intranas
intramuscular
im
oral
rout
furthermor
vsv
accommod
larg
insert
foreign
gene
whose
express
control
base
site
gene
insert
vsv
genom
recombin
induc
potent
humor
cellular
immun
respons
varieti
anim
model
numer
studi
shown
recombin
vsv
vector
express
appropri
foreign
antigen
highli
effect
experiment
vaccin
earlier
studi
show
rvsv
vector
express
yersinia
pesti
lcrv
gene
confer
highlevel
longterm
protect
intranas
plagu
challeng
mice
singl
booster
immun
previou
studi
use
multipledos
dna
vaccin
found
secret
form
lcrv
induc
improv
antibodi
respons
better
protect
mice
challeng
present
studi
incorpor
gene
encod
secret
form
lcrv
vsv
vector
vsvsslcrv
test
efficaci
singledos
vaccin
lethal
plagu
challeng
vector
elicit
robust
antibodi
respons
increas
immun
dose
mice
confer
complet
protect
pulmonari
pesti
challeng
presenc
vaccin
induc
cell
time
challeng
import
gener
complet
protect
plasmid
use
deriv
vsv
recombin
express
secret
form
low
calcium
respons
protein
v
lcrv
yersinia
pesti
gener
follow
sslcrv
code
region
contain
signal
sequenc
human
plasminogen
activ
protein
upstream
lcrv
open
read
frame
orf
amplifi
pcr
use
pbslcrv
plasmid
templat
signal
sequenc
ad
upstream
lcrv
orf
forward
primer
pcr
perform
use
vent
dna
polymeras
new
england
biolab
forward
primer
gtcgacaacatggatgcaatgaa
gagagggctctgctgtgtgctgctgctg
tgtggagcagtcttcgt
ttcgattagagcctacgaacaaaaccc
sequenc
encod
signal
underlin
follow
nd
codon
lcrv
revers
primer
tccccccgggctagctcatttaccagacgtgtcatcta
gcag
forward
revers
primer
respect
introduc
sal
nhe
restrict
enzym
site
bold
upstream
downstream
sslcrv
code
sequenc
pcr
product
digest
sal
nhe
purifi
ligat
xho
inh
digest
gener
recombin
vsv
express
secret
lcrv
first
posit
vsv
genom
recov
plasmid
describ
previous
briefli
babi
hamster
kidney
cell
grown
confluenc
infect
vaccinia
viru
recombin
express
rna
polymeras
multipl
infect
moi
hr
follow
transfect
along
support
plasmid
pbsn
pbsp
pbsl
hr
post
transfect
cell
supernat
passag
onto
fresh
cell
medium
contain
viru
collect
hr
viru
stock
prepar
individu
plaqu
grown
cell
store
cell
seed
glass
cover
slip
infect
recombin
wildtyp
rwt
vsv
hr
post
infect
cell
wash
twice
phosphat
buffer
salin
pb
fix
para
formaldehyd
room
temperatur
follow
cell
wash
pb
contain
glycin
pbsglycin
permeabil
pbsglycin
cell
incub
equal
mixtur
dilut
antilcrv
monoclon
antibodi
mab
santa
cruz
biotechnolog
ca
follow
incub
goat
antimous
alexa
flour
igg
molecular
probe
eugen
dilut
cell
wash
twice
pbsglycin
mount
slide
imag
use
nikon
eclips
fluoresc
microscop
equip
nikon
plan
apochromat
oil
object
photometr
coolsnap
camera
cell
infect
recombin
virus
moi
hr
cell
wash
methioninefre
dulbecco
modifi
eagl
medium
dmem
follow
label
methionin
hr
cell
supernat
collect
infect
cell
wash
pb
lyse
deterg
lysi
buffer
nonidet
deoxychol
trishcl
mm
edta
ice
min
prepar
lysat
lysat
supernat
clarifi
g
min
analyz
sdspage
protein
band
visual
autoradiographi
six
eight
weekold
balbc
femal
mice
obtain
either
charl
river
laboratori
tacon
laboratori
rest
minimum
week
inocul
anim
hous
condit
microisol
cage
virus
dilut
serum
free
dmem
mice
vaccin
intramuscularli
im
left
hind
leg
muscl
dose
viru
indic
text
total
volum
immun
perform
yale
univers
immun
challeng
carri
public
health
research
institut
phri
newark
nj
approv
respect
institut
anim
care
use
committe
serum
sampl
heat
inactiv
min
enzym
link
immunosorb
assay
elisa
determin
total
serum
antibodi
specif
lcrv
perform
describ
palin
et
al
minor
modif
briefli
ng
purifi
gstlcrv
protein
northeast
biodefens
center
nbc
protein
express
core
wadsworth
center
ny
captur
buffer
mm
trishcl
ph
nacl
ad
well
plate
corn
hr
plate
block
bovin
serum
pb
min
serial
dilut
serum
sampl
duplic
ad
plate
incub
hr
room
temperatur
goatantimous
secondari
antibodi
conjug
horseradish
peroxidas
hrp
ad
dilut
incub
hr
immunopur
abt
tablet
pierc
dissolv
ml
substrat
buffer
acet
tween
ph
h
ad
use
substrat
solut
plate
read
nm
biorad
micropl
reader
min
follow
addit
substrat
titer
calcul
reciproc
maximum
serum
dilut
give
od
subtract
nonspecif
bind
serum
recombin
vsv
express
enhanc
green
fluoresc
protein
egfp
first
posit
infect
anim
elisa
assay
determin
level
bound
specif
lcrv
perform
describ
section
except
use
hrpconjug
goat
antimous
use
dilut
use
dilut
calcul
amount
bound
lcrv
also
gener
standard
curv
use
rang
concentr
mous
sigma
bound
directli
elisa
plate
detect
hrpconjug
goat
antimous
sigma
determin
extent
andor
cell
deplet
mab
femal
balbc
mice
obtain
charl
river
laboratori
rest
week
administr
rat
antimous
mab
specif
mous
clone
andor
mous
clone
intraperiton
ip
rout
control
anim
either
inject
isotyp
control
rat
clone
left
untreat
mab
purchas
bio
express
cell
cultur
servic
west
lebanon
nh
splenocyt
isol
anim
three
day
post
mab
inject
stain
phycoerythrin
pe
conjug
rat
antimous
antibodi
pharmingen
allophycocyanin
apc
conjug
rat
antimous
antibodi
pharmingen
cell
deplet
splenocyt
assess
fac
calibur
flow
cytomet
bd
bioscienc
san
jose
ca
analyz
use
flowjo
analysi
softwar
tree
star
inc
san
carlo
ca
depletionchalleng
studi
vaccin
mice
inject
ip
mg
isotyp
control
andor
mab
indic
one
day
prior
day
challeng
challeng
work
pesti
perform
biosafeti
cabinet
anim
facil
phri
nj
mice
vaccin
im
challeng
ld
cfu
pesti
strain
rout
volum
follow
anesthet
ketamin
xylazin
mgkg
mgkg
bodi
weight
respect
liquid
inocula
deliv
nare
mice
time
use
pipettman
aerosol
barrier
tip
mice
challeng
indic
time
postinocul
observ
daili
day
anim
exhibit
extrem
lethargi
distress
period
euthan
gener
recombin
vsv
express
secret
form
pesti
lcrv
protein
dna
sequenc
encod
signal
sequenc
ss
secret
ad
upstream
lcrv
orf
insert
plasmid
vector
allow
recoveri
viru
fig
express
secret
form
lcrv
first
posit
vsv
genom
posit
maxim
mrna
protein
express
vsv
transcript
occur
sequenti
start
transcript
attenu
subsequ
gene
junction
appropri
vsvspecif
transcript
start
stop
polyadenyl
signal
flank
sslcrvcode
region
incorpor
indic
fig
recov
viru
grew
titer
nearli
equival
wildtyp
vsv
normal
plaqu
size
verifi
express
secret
lcrv
protein
examin
local
cell
infect
cell
recombin
wildtyp
rwt
vsv
perform
indirect
immunofluoresc
microscopi
use
two
monoclon
antibodi
mab
lcrv
protein
shown
fig
protein
encod
present
reticular
network
throughout
cytoplasm
pattern
expect
secret
protein
endoplasm
reticulum
contrast
lcrv
protein
encod
show
diffus
cytoplasm
local
control
cell
infect
rwtvsv
show
stain
lcrv
protein
differenti
interfer
contrast
dic
imag
includ
show
presenc
cell
field
express
secret
lcrv
protein
also
verifi
metabol
label
infect
cell
methionin
follow
analysi
lysat
supernat
infect
cell
sdspage
autoradiographi
fig
vsv
shut
host
protein
synthesi
cell
lysat
rvsvinfect
cell
show
mainli
viral
encod
protein
l
g
n
p
fig
highlevel
express
protein
expect
mobil
lcrv
identifi
cell
lysat
supernat
cell
infect
fig
lane
confirm
secret
sslcrv
protein
control
cell
infect
express
protein
cell
lysat
medium
fig
lane
lcrv
band
absent
lysat
supernat
mock
infect
cell
cell
infect
rwtvsv
fig
lane
earlier
work
show
singl
intranas
immun
pfu
gener
lowlevel
variabl
protect
pesti
challeng
gener
vector
express
secret
lcrv
evalu
antibodi
respons
gener
vector
singl
vaccin
pfu
gener
modestli
improv
protect
intranas
pesti
challeng
compar
shown
determin
better
protect
could
obtain
use
higher
immun
dose
initi
dose
respons
studi
previou
studi
vsv
vector
shown
littl
effect
viru
dose
given
intranas
substanti
effect
dose
given
intramuscular
im
rout
kapadia
jk
rose
unpublish
result
therefor
test
effect
viru
dose
antibodi
respons
given
im
initi
studi
five
group
mice
five
mice
per
group
immun
im
escal
dose
pfu
group
three
mice
receiv
control
viru
rout
blood
collect
mice
day
post
immun
dpi
antilcrv
titer
pool
sera
determin
use
elisa
shown
fig
escal
im
dose
rang
pfu
elicit
increas
antilcrv
titer
improv
time
increas
promin
two
higher
dose
group
pfu
twofold
increas
antilcrv
titer
pfu
group
rel
pfu
group
order
determin
higher
dose
might
potenti
pathogen
mice
also
weigh
mice
daili
two
week
follow
vsv
immun
shown
amount
kinet
weight
loss
mice
sensit
measur
viral
pathogenesi
weight
loss
neglig
mice
immun
pfu
similar
receiv
control
viru
mice
pfu
dose
group
show
transient
weight
loss
post
immun
began
recov
day
mice
pfu
dose
group
show
greatest
weight
loss
day
mice
recov
preimmun
bodi
weight
day
four
dose
respons
studi
show
could
achiev
high
antilcrv
titer
singl
high
dose
compar
antibodi
respons
degre
protect
pesti
challeng
confer
increas
dose
vector
use
earlier
immun
timelin
challeng
studi
repres
fig
three
group
eight
mice
vaccin
im
dose
pfu
parallel
three
addit
group
receiv
dose
eight
control
mice
immun
im
blood
collect
indic
timepoint
fig
antilcrv
titer
determin
use
pool
sera
immun
group
increas
dose
either
viru
led
increas
antibodi
titer
addit
titer
induc
gener
higher
induc
fig
analysi
igg
subclass
bind
lcrv
protein
pfu
dose
show
vaccin
induc
lcrvspecif
respons
higher
respons
fig
contrast
vaccin
induc
similar
level
lcrvspecif
fig
measur
efficaci
singl
dose
recombin
vsv
vaccin
anim
immun
group
subject
pulmonari
challeng
ld
pesti
strain
month
post
vaccin
group
seven
eight
anim
pfu
group
surviv
challeng
fig
four
eight
anim
surviv
pfu
group
one
eight
mice
surviv
pfu
group
fig
mice
control
group
die
day
postchalleng
higher
level
protect
pfu
group
statist
highli
signific
p
fisher
exact
test
compar
control
vaccin
anim
comparison
pfu
group
set
three
eight
anim
surviv
challeng
none
surviv
pfu
group
fig
differ
surviv
vaccin
vaccin
anim
dose
approach
statist
signific
first
experi
second
experi
anim
per
group
use
dose
vector
challeng
obtain
protect
vaccin
anim
protect
vaccin
anim
differ
highli
signific
p
earlier
passiv
transfer
studi
shown
antibodi
lcrv
suffici
provid
protect
diseas
mous
model
although
studi
increas
antibodi
titer
lcrv
gener
yield
higher
protect
analysi
antibodi
respons
individu
mice
often
correl
well
protect
comparison
mous
surviv
profil
antilcrv
titer
pfu
dose
group
reveal
larg
variat
titer
among
individu
mice
mice
low
titer
surviv
pesti
challeng
fig
lcrv
antibodi
titer
correl
complet
protect
fig
thought
cellular
immun
respons
might
contribut
protect
pulmonari
plagu
infect
induc
vsv
vector
examin
potenti
role
cell
vaccin
mice
time
challeng
deplet
cell
singli
togeth
challeng
determin
extent
protect
control
experi
perform
evalu
extent
deplet
use
mous
specif
mab
figur
show
repres
fac
plot
splenocyt
obtain
mice
inject
intraperitoneali
ip
isotyp
control
mab
stain
appropri
conjug
rat
antimous
antibodi
rel
isotyp
control
mab
treat
mous
andor
mab
treatment
result
nearli
complet
specif
deplet
andor
cell
mice
confirm
effici
deplet
fig
figur
give
plan
timelin
depletionchalleng
studi
four
group
ten
mice
group
ad
given
pfu
im
rout
ten
control
mice
receiv
similar
dose
andor
cell
deplet
immun
group
inject
ip
mab
specif
mous
mous
indic
fig
follow
pulmonari
pesti
challeng
approxim
month
post
vaccin
complet
protect
p
fisher
exact
test
compar
vaccin
mice
obtain
vaccin
anim
receiv
isotyp
control
mab
group
mab
group
c
shown
fig
contrast
two
group
vaccin
mice
receiv
mab
without
deplet
cell
group
b
elicit
significantli
reduc
fisher
exact
test
level
protect
note
greater
statist
signific
achiev
latter
case
anim
involv
calcul
surprisingli
one
ten
control
anim
surviv
challeng
previou
studi
mice
given
challeng
control
mice
die
day
post
challeng
earlier
studi
show
intranas
primeboost
immun
two
differ
vsv
vector
express
lcrv
elicit
highlevel
protect
pesti
challeng
report
develop
rvsv
vector
express
secret
form
lcrv
first
posit
vsv
genom
given
intramuscularli
im
singl
dose
pfu
induc
highlevel
antilcrv
antibodi
titer
mice
complet
protect
anim
subsequ
lethal
pulmonari
pesti
challeng
compar
vector
express
nonsecret
lcrv
describ
earlier
vector
express
secret
lcrv
gave
significantli
better
singledos
protect
immun
also
elicit
higher
rel
titer
suggest
shift
toward
h
type
immun
respons
secret
protein
although
basi
protect
lcrvbase
vaccin
complet
understood
sever
studi
shown
correl
high
antilcrv
titer
protect
addit
passiv
transfer
polyclon
lcrv
specif
antibodi
well
lcrv
monoclon
antibodi
mab
treatment
shown
protect
mous
model
plagu
infect
lcrv
antibodi
suffici
protect
studi
observ
prechalleng
lcrv
elisa
titer
correl
complet
protect
anim
even
low
titer
protect
instanc
also
note
nonhuman
primat
model
plagu
infect
anim
possess
high
lcrv
antibodi
titer
succumb
pesti
challeng
togeth
result
suggest
possibl
cellular
immun
compon
protect
recent
immun
live
replic
pesti
also
shown
import
cellmedi
immun
protect
plagu
challeng
howev
lcrv
appear
major
induc
tcell
respons
studi
studi
induct
increas
respons
lcrv
follow
immun
indic
antigenspecif
bia
toward
h
cellular
immun
respons
determin
could
identifi
role
cellular
immun
protect
perform
select
deplet
mous
andor
tcell
time
challeng
mice
complet
deplet
tcell
prior
challeng
protect
diseas
indic
tcell
requir
protect
howev
deplet
tcell
without
deplet
cell
significantli
reduc
level
protect
result
suggest
tcell
might
involv
protect
although
effect
cell
rule
effect
antibodi
product
unlik
deplet
perform
prior
challeng
consist
find
tcell
epitop
report
lcrv
protein
balbc
mice
tcell
epitop
defin
role
might
tcell
play
protect
pesti
vaccin
induc
tcell
known
secret
phagocyt
activ
type
cytokin
like
interferon
gamma
tumor
necrosi
factor
alpha
contribut
intracellular
antimicrobi
defens
activ
macrophag
howev
although
intracellular
nich
pesti
exist
pulmonari
plagu
infect
consid
predominantli
extracellular
recent
studi
suggest
cell
play
critic
role
combat
extracellular
bacteri
infect
studi
impli
import
role
protect
lethal
pesti
infect
thu
deplet
vaccin
prime
tcell
lead
abrog
cytokin
secret
activ
might
reflect
reduc
level
protect
observ
addit
role
cytotox
tcell
elimin
infect
cell
also
rule
addit
amino
termin
signal
sequenc
secret
lcrv
protein
enhanc
protect
unclear
also
note
previous
multidos
dna
vaccin
express
secret
lcrv
author
studi
suggest
aggreg
secret
protein
might
involv
greater
induct
antibodi
inclus
signal
sequenc
show
caus
effici
secret
lcrv
could
also
respons
enhanc
tcell
respons
secret
protein
effici
direct
mhc
class
ii
present
pathway
doserespons
antilcrv
serum
titer
immun
mice
mice
five
differ
group
immun
intramuscularli
im
day
pfu
blood
collect
retroorbit
bleed
day
post
inocul
serum
sampl
pool
total
igg
titer
specif
lcrv
determin
indic
day
use
elisa
deplet
tcell
mice
use
mous
specif
mab
repres
fac
plot
shown
splenocyt
obtain
mice
inject
intraperitoneali
ip
antimous
isotyp
control
top
left
top
right
bottom
left
combin
bottom
right
mab
stain
approrpi
conjug
rat
antimous
antibodi
day
post
inject
